ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,068.79
0.29%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Capricor Therapeutics Inc (CAPR)

  7. Capricor Therapeutics Inc (CAPR) Noticias

CAPR Capricor Therapeutics Inc

5.47
0.23 (4.39%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Capricor Therapeutics Inc CAPR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.23 4.39% 5.47 18:59:59
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.28 5.28 5.7799 5.47 5.24
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202408:00GLOBECapricor Therapeutics Announces Positive Type-B Meeting with..
21/3/202407:30GLOBECapricor Therapeutics to Present at Upcoming Investor..
11/3/202407:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202415:06EDGAR2Form 8-K - Current report
29/2/202415:05GLOBECapricor Therapeutics Reports Fourth Quarter and Full Year..
27/2/202407:30GLOBECapricor Therapeutics Announces Upcoming Type-B Meeting with..
22/2/202407:30GLOBECapricor Therapeutics to Present Fourth Quarter and Full..
20/2/202407:30GLOBECapricor Therapeutics Announces Manufacturing Scale-Up of..
16/2/202416:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
24/1/202408:15GLOBECapricor Therapeutics Announces Collaboration with the..
11/1/202408:00EDGAR2Form 8-K - Current report
04/1/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202315:30EDGAR2Form 8-K - Current report
24/10/202308:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202315:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/10/202312:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202308:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202308:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202308:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202308:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202316:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/9/202316:00EDGAR2Form 8-K - Current report
29/9/202316:00EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
29/9/202306:30EDGAR2Form 8-K - Current report
06/9/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202317:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/9/202308:01EDGAR2Form 8-K - Current report
16/8/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202307:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202315:06EDGAR2Form 8-K - Current report
24/7/202316:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202316:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/7/202307:35EDGAR2Form 8-K - Current report
13/7/202315:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202315:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/7/202307:31EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
CAPR
Capricor Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados